Bank Of America Corp Kymera Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 151,191 shares of KYMR stock, worth $7.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

151,191

Previous 162,291 6.84%

Holding current value

$7.48 Million

Previous $6.52 Million 30.82%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$29.85 - $39.42 $331,335 - $437,562	-11,100 Reduced 6.84%	151,191 $4.51 Million
Q1 2024 May 15, 2024	BUY	$22.9 - $43.57 $3.03 Million - $5.76 Million	132,293 Added 441.01%	162,291 $6.52 Million
Q4 2023 Feb 14, 2024	SELL	$10.97 - $26.84 $1.21 Million - $2.95 Million	-110,026 Reduced 78.58%	29,998 $763,000
Q2 2023 Aug 14, 2023	SELL	$22.4 - $34.92 $3.06 Million - $4.78 Million	-136,764 Reduced 49.41%	140,024 $3.22 Million
Q1 2023 May 12, 2023	BUY	$24.84 - $38.75 $1.74 Million - $2.71 Million	69,905 Added 33.79%	276,788 $8.2 Million
Q4 2022 Feb 10, 2023	BUY	$19.57 - $30.92 $1.59 Million - $2.51 Million	81,307 Added 64.75%	206,883 $5.16 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $135,141 - $221,487	6,463 Added 5.43%	125,576 $2.73 Million
Q2 2022 Aug 12, 2022	SELL	$14.13 - $42.55 $143,066 - $430,818	-10,125 Reduced 7.83%	119,113 $2.35 Million
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $2.01 Million - $3.67 Million	56,818 Added 78.46%	129,238 $5.47 Million
Q4 2021 Feb 08, 2022	BUY	$49.91 - $65.56 $1.82 Million - $2.39 Million	36,414 Added 101.13%	72,420 $4.6 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $1.32 Million - $1.84 Million	27,654 Added 331.11%	36,006 $2.12 Million
Q2 2021 Sep 13, 2021	BUY	$31.08 - $51.95 $259,580 - $433,886	8,352 New	8,352 $405,000

Others Institutions Holding KYMR

# of Institutions

166

Shares Held

63.1M

Call Options Held

22.6K

Put Options Held

14.4K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.71B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Kymera Therapeutics, Inc. Transaction History